Stuart K Roberts
Overview
Explore the profile of Stuart K Roberts including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
189
Citations
2407
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Roberts S, Majeed A, Rasaratnam K, Olynyk J, Shackel N, Wood M, et al.
Cancer Med
. 2025 Feb;
14(5):e70722.
PMID: 40018806
Background/purpose Of The Study: The treatment landscape for very early to intermediate stage hepatocellular carcinoma (HCC) is rapidly evolving, with new data and treatments emerging in recent years. There is...
2.
Eslam M, Fan J, Yu M, Wong V, Cua I, Liu C, et al.
Hepatol Int
. 2025 Feb;
PMID: 40016576
Metabolic dysfunction-associated fatty liver disease (MAFLD) affects over one-fourth of the global adult population and is the leading cause of liver disease worldwide. To address this, the Asian Pacific Association...
3.
Janko N, Majeed A, Commins I, Gow P, Kemp W, Roberts S
Eur J Gastroenterol Hepatol
. 2025 Feb;
PMID: 39976046
Background And Aims: Emerging evidence suggests that rotational thromboelastometry (ROTEM) is superior to conventional haemostatic tests in the assessment and management of bleeding risk in patients with cirrhosis. Whether ROTEM...
4.
Vaz K, Kemp W, Majeed A, Lubel J, Magliano D, Glenister K, et al.
Hepatol Int
. 2024 Dec;
PMID: 39673677
Background And Aims: Controversy remains whether the mortality risk in people with fatty liver disease (FLD) including metabolic-(dysfunction) associated steatotic liver disease (MASLD) and metabolic-(dysfunction) associated fatty liver disease (MAFLD)...
5.
Abdelmalak J, Lubel J, Sinclair M, Majeed A, Kemp W, Roberts S
Hepatol Commun
. 2024 Dec;
9(1).
PMID: 39665645
There is significant variation in HCC management across different centers with poor adherence to evidence-based clinical practice guidelines as assessed in prior studies. In Australia, quality indicators (QIs) have recently...
6.
Clayton-Chubb D, Roberts S, Majeed A, Woods R, Tonkin A, Nelson M, et al.
Geroscience
. 2024 Nov;
47(1):1303-1318.
PMID: 39607592
The impact of metabolic dysfunction-associated steatotic liver disease (MASLD), the preferred nomenclature for NAFLD, on cardiovascular health and mortality among older adults is uncertain. As such, we aimed to identify...
7.
Vaz K, Kemp W, Majeed A, Lubel J, Magliano D, Glenister K, et al.
J Gastroenterol Hepatol
. 2024 Oct;
40(1):241-249.
PMID: 39444323
Background And Aim: The validity of non-invasive tests (NITs) of liver fibrosis for the prediction of liver and mortality outcomes in an Australian cohort is unknown. We aimed to verify...
8.
Abdelmalak J, Zalcberg J, Roberts S
JAMA Surg
. 2024 Sep;
159(12):1440-1441.
PMID: 39320909
No abstract available.
9.
Kalo E, Read S, Baig A, Marshall K, Ma W, Crowther H, et al.
JGH Open
. 2024 Sep;
8(9):e70029.
PMID: 39301299
The current treatment approach to patients with liver cirrhosis relies on the individual management of complications. Consequently, there is an unmet need for an overall therapeutic strategy for primary and...
10.
Clayton-Chubb D, Vaughan N, George E, Chan A, Roberts S, Ryan J, et al.
Nutrients
. 2024 Sep;
16(17).
PMID: 39275293
Dietary patterns contribute to overall health and diseases of ageing but are understudied in older adults. As such, we first aimed to develop dietary indices to quantify Mediterranean Diet Score...